NewAmsterdam Pharma Company
NAMS
$21.97
Share price
0.73%
Change (1 day)
49.76%
Change (1 year)
Categories
Earnings for NewAmsterdam Pharma Company (NAMS)
Earnings in 2023: -$0.18 B
According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2023 the company made an earning of -$0.18 B a decrease over its 2022 earnings that were of -$24.25 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for NewAmsterdam Pharma Company from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$0.18 B | 629.81% |
| 2022 | -$24.25 M | -48.78% |
| 2021 | -$47.33 M | 444.1% |
| 2020 | -$8.7 M |